Skip to content

RayStation 10.1

by RaySearch Laboratories AB (PUBL)

510(k) K210645

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

5 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK210645 Date29 Jun 2021ClearedStatusActive

Official records

From the FDA record

Received by the FDA
3 Mar 2021
FDA decision
29 Jun 2021 (Substantially Equivalent)
FDA review time
118 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K210645 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

6 recalls · 5 ongoing · FDA

    • Ongoing Z-1102-2026 FDA Class II initiated 28 Nov 2025

    Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.

    • Ongoing Z-2490-2025 FDA Class II initiated 8 Aug 2025

    DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.

    • Ongoing Z-1188-2025 FDA Class II initiated 16 Jan 2025

    Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.

    • Ongoing Z-1747-2024 FDA Class II initiated 28 Mar 2024

    Potential for reported SSD to be too high.

    • Ongoing Z-1482-2024 FDA Class II initiated 23 Feb 2024

    A use error that has occurred with RayStation/RayPlan, where material override using Silicon, Si, was incorrectly selected for a silicone gel polymer implant.

    • Terminated Z-0848-2022 FDA Class II initiated 9 Sep 2021

    If the dynamic jaw mode is used and an optimization is continued after changing the dose grid or modifying the target ROI, the positions of the jaws may change unexpectedly for some control points. User must be aware to avoid unnecessary jaw openings during treatment planning

Timeline

7 dated events

  1. Cleared FDA 510(k) K210645
  2. Recall initiated FDA recalls Z-0848-2022
  3. Recall initiated FDA recalls Z-1482-2024
  4. Recall initiated FDA recalls Z-1747-2024
  5. Recall initiated FDA recalls Z-1188-2025
  6. Recall initiated FDA recalls Z-2490-2025
  7. Recall initiated FDA recalls Z-1102-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MUJ
Device class
Class II
Regulation
21 CFR Part 892.5050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

RayStation 10.1 is a Radiation Therapy Treatment Planning System designed for advanced radiotherapy planning. It integrates multi-criteria optimization and adaptive therapy capabilities to support external beam therapy, brachytherapy, and particle therapy (including protons, helium, and carbon ions). The system facilitates precise dose calculations and treatment planning across diverse radiation modalities, enhancing treatment accuracy and customization for complex cases.

This software-based system is intended for use in radiology departments and oncology centers, where it aids clinicians in generating optimized treatment plans. Supplied as a standalone software solution, it requires compatible hardware and network infrastructure for operation. The device holds FDA 510(k) clearance (K210645) under the Radiology advisory committee, classified as a Class II medical device under regulation 892.5050. No sterility or single-use requirements apply, as it is a reusable digital platform.

Similar devices

Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).

Other devices from RaySearch Laboratories AB (PUBL)

See all devices from RaySearch Laboratories AB (PUBL) →